Drugs / Jianpi Lishi Jiedu Granules

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07505056 May → Dec 2026 expected colorectal adenoma Nanjing First Hospital, Nanjing Medical University Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Jianpi Lishi Jiedu Granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT07505056 ↗
Route Oral “orally administered” NCT07505056 ↗